Cormark Cuts Boralex (TSE:BLX) Price Target to C$35.00

Boralex (TSE:BLXFree Report) had its price target trimmed by Cormark from C$47.00 to C$35.00 in a report published on Thursday,BayStreet.CA reports.

Other analysts also recently issued research reports about the company. BMO Capital Markets decreased their price target on Boralex from C$46.00 to C$45.00 in a research note on Friday, November 15th. Scotiabank decreased their target price on Boralex from C$42.00 to C$36.00 and set a “sector perform” rating for the company in a research note on Thursday. Finally, CIBC decreased their target price on Boralex from C$42.00 to C$40.00 and set an “outperform” rating for the company in a research note on Wednesday, January 8th. One research analyst has rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Boralex has an average rating of “Buy” and a consensus price target of C$40.88.

Read Our Latest Stock Analysis on BLX

Boralex Stock Performance

BLX opened at C$25.05 on Thursday. The company has a market cap of C$2.57 billion, a PE ratio of 26.94, a price-to-earnings-growth ratio of 2.01 and a beta of 0.46. The stock has a 50-day moving average of C$28.32 and a 200-day moving average of C$31.93. Boralex has a 52-week low of C$24.40 and a 52-week high of C$36.68. The company has a debt-to-equity ratio of 175.24, a quick ratio of 1.54 and a current ratio of 0.95.

About Boralex

(Get Free Report)

Boralex Inc is an electric utility company involved in the development, construction, and operation of renewable energy power facilities. The company controls a portfolio of electricity producing plants that utilize wind, hydroelectric, thermal, and solar fuel sources. Most of Boralex’s plants rely on wind power, while a significant number also employ hydroelectric power.

Recommended Stories

Analyst Recommendations for Boralex (TSE:BLX)

Receive News & Ratings for Boralex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boralex and related companies with MarketBeat.com's FREE daily email newsletter.